Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 1,163.66 | 44.00 |
| PEG Ratio (TTM) | 9.09 | 0.63 |
| P/S Ratio (TTM) | 6.70 | 17.07 |
| P/B Ratio (TTM) | 2.29 | 14.65 |
| P/FCF Ratio (TTM) | 30.84 | 39.11 |
| Price to 5YR AVG Earnings Ratio | -60.60 | 62.34 |
| Price to 5YR AVG FCF Ratio | 129.42 | 92.48 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.09% | -3.25% |
| ROE (TTM) | 0.20% | 8.48% |
| Net Profit Margin (TTM) | 0.59% | 4.48% |
| ROIC 5YR AVG | -5.66% | 4.74% |
Growth (55%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 18.63% | -221.63% | -108.68% |
| Revenue | 4.14% | 88.69% | 70.57% |
| Net Income | 18.71% | -257.73% | -130.93% |
| Cash Flow | 15.67% | -99.73% | 177.41% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.53 | 1.85 |
| Quick Ratio (TTM) | 1.53 | 1.84 |
| D/E Ratio (TTM) | 0.20 | 0.52 |
| Interest Coverage (TTM) | -4.84 | 12.37 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 1.32 | 10.32 |
| LTL to 5YR AVG FCF | 14.05 | 3.97 |
| Shares Outstanding Growth 5YR AVG | 8.27% | 40.48% |